Each individual lot of a licensed drug product must be evaluated and approved prior to its release on the market. The regulatory authorities demand review of manufacturer's production data and results of quality control testing.
Quality control testing by a contracted laboratory, supports lot release by providing evidence of a guaranteed level of safety and quality of the released product, by a third, independent and impartial party. As an independent contracted laboratory, IBR Inc. supports lot release of biologics, biosimilars, vaccines and small molecules by means of a broad panel of bioanalytical services. Meeting customer production schedules is a key feature of our business.